论文部分内容阅读
目的探讨分析胃黏膜相关淋巴组织淋巴瘤临床治疗和预后。方法回顾性分析我院2001年1月～2011年1月间收治的22例胃黏膜相关淋巴组织淋巴瘤患者的临床资料,观察治疗情况及生存率。结果 22例胃黏膜相关淋巴组织淋巴瘤患者中,Ⅰ期患者14例,Ⅱ期患者5例,Ⅲ期患者2例,Ⅳ期患者1例。经手术完全切除病变患者20例,经手术部分切除病变患者2例,手术后患者行放、化疗。经跟踪随访,22例胃黏膜相关淋巴组织淋巴瘤患者的5年生存率为77.27%(17/22),10年生存率为50.00%(11/22)。结论胃黏膜相关淋巴组织淋巴瘤患者的预后与临床分期和手术治疗的效果有直接关系,及早对胃黏膜相关淋巴组织淋巴瘤进行诊断确诊,采取积极有效的治疗,能够提高患者的生存率。
Objective To investigate the clinical treatment and prognosis of gastric mucosa-associated lymphoid tissue lymphoma. Methods The clinical data of 22 patients with gastric mucosa-associated lymphoid tissue lymphoma treated in our hospital from January 2001 to January 2011 were retrospectively analyzed. The treatment and survival rate were observed. Results Among the 22 cases of gastric mucosa-associated lymphoid tissue lymphoma, 14 cases were stage Ⅰ, 5 cases were stage Ⅱ, 2 cases were stage Ⅲ and 1 was stage Ⅳ. Twenty patients underwent complete resection of the lesion and 2 patients underwent partial resection of the lesion by surgery. The patients underwent postoperative radiotherapy and chemotherapy. The follow-up of follow-up showed that the 5-year survival rate was 77.27% (17/22) in 22 cases of gastric mucosa-associated lymphoid tissue lymphoma and 50.00% (10/22) in 10-year survival rate. Conclusions The prognosis of patients with gastric mucosa-associated lymphoid tissue lymphoma is directly related to the clinical stage and the effect of surgical treatment. Diagnosis and diagnosis of gastric mucosa-associated lymphoid tissue lymphoma are possible as early as possible. Active and effective treatment can improve the survival rate of patients.